Get the Stockscreener App
77.92
0.13%
0.10
Pre-market:
77.01
-0.91
-1.17%
Lantheus Holdings Inc stock is traded at $77.92, with a volume of 966.98K.
It is up +0.13% in the last 24 hours and down -4.09% over the past month.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
See More
Previous Close:
$77.82
Open:
$77
24h Volume:
966.98K
Relative Volume:
0.93
Market Cap:
$5.56B
Revenue:
$1.50B
Net Income/Loss:
$427.61M
P/E Ratio:
12.97
EPS:
6.01
Net Cash Flow:
$423.98M
1W Performance:
-3.11%
1M Performance:
-4.09%
6M Performance:
-15.91%
1Y Performance:
-5.70%
1-Day Range:
$76.48
$78.72
1-Week Range:
$76.34
$83.06
52-Week Range:
$73.11
$126.89
Lantheus Holdings Inc Stock (LNTH) Company Profile
Name
Lantheus Holdings Inc
Sector
Phone
978 671-8001
Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
77.92 | 5.56B | 1.50B | 427.61M | 423.98M | 6.01 |
|
RGC
Regencell Bioscience Holdings Ltd
|
78.00 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
161.67 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.50 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.89 | 47.60B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.89 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Goldman | Buy |
| Sep-03-24 | Initiated | Redburn Atlantic | Buy |
| Jul-10-24 | Reiterated | JMP Securities | Mkt Outperform |
| Dec-18-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-04-23 | Initiated | TD Cowen | Outperform |
| Sep-29-23 | Initiated | William Blair | Outperform |
| Mar-08-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-30-22 | Initiated | SVB Leerink | Outperform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| May-09-22 | Initiated | B. Riley Securities | Buy |
| Apr-13-22 | Initiated | Truist | Buy |
| Feb-01-21 | Initiated | SVB Leerink | Outperform |
| Jun-29-20 | Resumed | Jefferies | Buy |
| Aug-16-19 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Nov-02-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Nov-08-16 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-23-16 | Resumed | Credit Suisse | Neutral |
| Feb-24-16 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-11-15 | Downgrade | Credit Suisse | Outperform → Neutral |
| Sep-30-15 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jul-20-15 | Initiated | Credit Suisse | Outperform |
| Jul-20-15 | Initiated | Jefferies | Buy |
| Jul-20-15 | Initiated | RBC Capital Mkts | Outperform |
| Jul-20-15 | Initiated | Robert W. Baird | Outperform |
| Jul-20-15 | Initiated | Wells Fargo | Outperform |
View All
Lantheus Holdings Inc Stock (LNTH) Latest News
Alzheimer’s Association Parnters with Lantheus for 30th Annual Charity Golf Tournament - The Bedford Citizen
Lantheus at 2025 Truist Securities MedTech Conference: Strategic Growth Path - Investing.com Nigeria
(LNTH) Technical Data - news.stocktradersdaily.com
The total return for Lantheus Holdings (NASDAQ:LNTH) investors has risen faster than earnings growth over the last five years - simplywall.st
Lantheus Announces Presentations to be featured at the 2025 Soci - GuruFocus
Insider Sell: Julie Mchugh Sells Shares of Lantheus Holdings Inc (LNTH) - GuruFocus
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting - The Manila Times
Lantheus Holdings, Inc. to Present New Data on Oncology Radiodiagnostics at 2025 SNMMI Annual Meeting - Nasdaq
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and ... - Eagle-Tribune
Lantheus Unveils Breakthrough Cancer Diagnostic Results at SNMMI 2025: Multiple Studies Show Promise - Stock Titan
Lantheus at Goldman Sachs Conference: Strategic Expansion in Healthcare By Investing.com - Investing.com South Africa
Lantheus at Goldman Sachs Conference: Strategic Expansion in Healthcare - Investing.com
Transcript : Lantheus Holdings, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 02 - marketscreener.com
Lantheus to Present at the 2025 Truist Securities MedTech Conference - The Manila Times
Lantheus CEO Reveals Growth Strategy: Key Insights Coming at Truist MedTech Conference - Stock Titan
Declining Stock and Solid Fundamentals: Is The Market Wrong About Lantheus Holdings, Inc. (NASDAQ:LNTH)? - Yahoo Finance
Investor Network: Lantheus Holdings Inc. to Host Earnings Call - ACCESS Newswire
Investor Network: Lantheus Holdings Inc to Host Earnings Call - ACCESS Newswire
Lantheus to Present at the Goldman Sachs 46th Annual Global Heal - GuruFocus
Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 | LNTH Stock News - GuruFocus
Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - The Manila Times
Lantheus CEO to Share Radiopharmaceutical Innovation Strategy at Goldman Sachs Healthcare Conference - Stock Titan
How to Take Advantage of moves in (LNTH) - news.stocktradersdaily.com
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer - Quantisnow
Lantheus Holdings Inc (LNTH) Shares Up 3.1% on May 27 - GuruFocus
Learn to Evaluate (LNTH) using the Charts - news.stocktradersdaily.com
Lantheus Holdings stock hits 52-week low at $74.92 By Investing.com - Investing.com India
Lantheus Holdings’ SWOT analysis: diagnostic imaging leader faces market shifts - Investing.com India
Lantheus Holdings stock hits 52-week low at $74.92 - Investing.com
Lantheus Holdings, Inc.'s (NASDAQ:LNTH) 25% Cheaper Price Remains In Tune With Earnings - simplywall.st
Lantheus Holdings, Inc. (NASDAQ:LNTH) Receives $132.67 Average PT from Brokerages - Defense World
Cetera Investment Advisers Grows Holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Lantheus Holdings Inc (LNTH) Stock Price Down 2.68% on May 19 - GuruFocus
Lantheus Holdings, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsLNTH - ACCESS Newswire
Lantheus Holdings: Poor Results Caused By Temporary ProblemsA Buy - Seeking Alpha
Radiopharmaceuticals Market Products and Applications Report 2025 | SPECT Radiopharmaceuticals Lead Diagnostic Market with 67% Share - GlobeNewswire Inc.
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore - MarketBeat
Lantheus Holdings (NasdaqGM:LNTH) Adjusts 2025 Earnings Guidance - Yahoo Finance
Shareholders that lost money on Lantheus Holdings, Inc. (LNTH) should contact Levi & Korsinsky about Securities Fraud InvestigationLNTH - ACCESS Newswire
Long Term Trading Analysis for (LNTH) - news.stocktradersdaily.com
Lantheus Holdings, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsLNTH - ACCESS Newswire
Lantheus projects $1.55B-$1.585B revenue for 2025 amid acquisitions and market growth - MSN
Lantheus Holdings stock drops on lowered full year outlook - MSN
LNTH Q1 Earnings Call: Lantheus Lowers Outlook Amid Product Shifts and Divestitures - Yahoo Finance
Shareholder Rights Advocates at Levi & Korsinsky Investigate Lantheus Holdings, Inc. (LNTH) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Lantheus price target lowered to $120 from $134 at JonesResearch - Yahoo Finance
Lantheus Holdings, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - Yahoo Finance
Truist cuts Lantheus stock price target to $117, maintains Buy By Investing.com - Investing.com South Africa
Lantheus announces pivotal trial win for Alzheimer’s imaging agent - MSN
LNTH: Sale of SPECT Tilts Growth to Novel Radiopharmaceuticals - Research Tree
Lantheus Holdings Inc earnings missed by $0.11, revenue fell short of estimates - Investing.com Nigeria
Lantheus Holdings Inc Stock (LNTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):